Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) Resignation of Executive Officer On March 29, 2026, Timothy Williams notified Vanda Pharmaceuticals Inc. (the “Company”) of his resignation as the Company’s Senior Vice President, General Counsel and Secretary, effective as of April 10, 2026, in order to pursue other endeavors.
VNDA Vanda Pharmaceuticals Inc. - 8-K
Accession
0001628280-26-0232225.02
Item 5.02 - Departure/Election of Directors or Certain Officers
62 words